According to a new market research report titled, ‘Africa In Vitro Diagnostics Market by Product & Solution, Technology (Immunoassay, Point of Care, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), End User — Forecast to 2030,’ published by Meticulous Research®, the Africa in vitro diagnostics market is expected to reach $1.49 billion by 2030, at a CAGR of 2.8% from 2023 to 2030.
In vitro diagnostics (IVD) are tests performed on samples of blood or tissue taken from the human body to detect a wide range of diseases. These tests help monitor overall health to prevent and treat various diseases. IVD involves the use of various reagents, assays, and kits based on technologies such as immunoassay, whole blood glucose monitoring, molecular diagnostics, point of care, clinical chemistry, hematology, coagulation & hemostasis, critical care, and urinalysis.